Prostate-specific membrane antigen-based imaging.

@article{Osborne2013ProstatespecificMA,
  title={Prostate-specific membrane antigen-based imaging.},
  author={J. Osborne and N. Akhtar and S. Vallabhajosula and Alok Anand and K. Deh and S. Tagawa},
  journal={Urologic oncology},
  year={2013},
  volume={31 2},
  pages={
          144-54
        }
}
Prostate cancer (CaP) is the most common noncutaneous malignancy affecting men in North America. Despite significant efforts, conventional imaging of CaP does not contribute to patient management as much as imaging performed for other common cancers. Given the lack of specificity in conventional imaging techniques, one possible solution is to screen for CaP-specific antigenic targets and generate agents able to specifically bind. Prostate-specific membrane antigen (PSMA) is overexpressed in CaP… Expand
[Ga-68-PSMA PET/CT for prostate cancer].
Molecular imaging of urogenital diseases.
PSMA-targeted dendrimers: a patent evaluation (WO2012078534)
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 62 REFERENCES
PET Imaging of Prostate Cancer Xenografts with a Highly Specific Antibody against the Prostate-Specific Membrane Antigen
Technology Insight: monoclonal antibody imaging of prostate cancer
  • N. Bander
  • Medicine
  • Nature Clinical Practice Urology
  • 2006
Preclinical evaluation of a monoclonal antibody (3C6) specific for prostate-specific membrane antigen.
Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer
Anti–prostate‐Specific membrane antigen‐based radioimmunotherapy for prostate cancer
Tc-99m labeled small-molecule inhibitors of prostate-specific membrane antigen (PSMA): New molecular imaging probes to detect metastatic prostate adenocarcinoma (PC).
  • J. Osborne, N. Akhtar, +10 authors J. Babich
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2012
...
1
2
3
4
5
...